medigraphic.com
SPANISH

Ginecología y Obstetricia de México

Federación Mexicana de Ginecología y Obstetricia, A.C.
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2020, Number 10

<< Back Next >>

Ginecol Obstet Mex 2020; 88 (10)

Basic concepts in reproductive immunology: a narrative review of the literature

Rodríguez-Purata J, Cervantes-Bravo E
Full text How to cite this article

Language: Spanish
References: 41
Page: 692-699
PDF size: 228.55 Kb.


Key words:

Reproductive medicine, Recurrent miscarriage, IVF, Embryo implantation, Immune tolerance, Placentation, HLA-C antigens, Antigen presentation.

ABSTRACT

Background: Reproductive immunology is not a new area in reproductive medicine, it has always been related to recurrent miscarriage and repeated implantation failure, especially in the context of IVF. Recently, new concepts have emerged that are important for OBGYN specialists to keep in mind.
Objective: Interrelating the basic concepts of immunology, embryology and assisted reproduction to better understand what the former can and cannot solve.
Methodology: Retrospective study based on the electronic search, carried out in February 2020, in the databases: PubMed and Google Scholar with the following terms (MeSH) The following MeSH terms were used: Abortion, Spontaneous/immunology; Embryo Implantation/immunology; HLA-C Antigens/immunology; Immune Tolerance/ immunology; Immunity, Maternally-Acquired/immunology; Uterus/immunology; Killer Cells, Natural/immunology; Placentation/immunology; Receptors, KIR/immunology; Antigen Presentation/genetics; Antigen Presentation/immunology; Maternal-Fetal Exchange/genetics; Maternal-Fetal Exchange/immunology.
Results: 289 articles were collected, and 248 articles were deleted because they did not meet the inclusion criteria; only 41 were analyzed. The articles identified served as a basis for updating the status of immunology in the context of reproductive medicine. During the process, other articles were reviewed to serve as bibliographic support for the concepts described in this review.
Conclusions: Due to the outstanding interest in the study of embryo genetics, reproductive medicine focused more on it and left immunology aside. However, since genetics still cannot adequately explain implantation failures, reproductive immunology is gaining momentum again.


REFERENCES

  1. Medawar BP, et al. Some immunological and endocrinological problems raised by the evolution of viviparity in vertebrates. Symp Soc Exp Biol 1953; 7: 320-37.

  2. Clark DA. Controversies in reproductive immunology. Crit Rev Immunol. 1991;11 (3-4): 215-47. PMID: 1817556

  3. Forman EJ, et al. In vitro fertilization with single euploid blastocyst transfer: a randomized controlled trial. Fertil Steril. 2013; 100 (1): 100-7.e1. doi:10.1016/j.fertnstert. 2013.02.056

  4. Scott RT, et al. Blastocyst biopsy with comprehensive chromosome screening and fresh embryo transfer significantly increases in vitro fertilization implantation and delivery rates: a randomized controlled trial. Fertil Steril. 2013; 100 (3): 697-703. doi:10.1016/j.fertnstert.2013.04.035

  5. Rodríguez-Purata J, et al. Reproductive outcome is optimized by genomic embryo screening, vitrification, and subsequent transfer into a prepared synchronous endometrium. J Assist Reprod Genet. 2016; 33 (3): 401-12. doi:10.1007/ s10815-016-0647-y

  6. Munné S, et al. Preimplantation genetic testing for aneuploidy versus morphology as selection criteria for single frozen-thawed embryo transfer in good-prognosis patients: a multicenter randomized clinical trial. Fertil Steril. 2019; 112 (6): 1071-79.e7. doi:10.1016/j.fertnstert.2019.07.1346

  7. Fernandez N, et al. A critical review of the role of the major histocompatibility complex in fertilization, preimplantation development and feto-maternal interactions. Hum Reprod Update. 1999; 5 (3): 234-48. doi:10.1093/humupd/5.3.234

  8. Wieczorek M, et al. Major histocompatibility complex (MHC) class I and MHC class II proteins: conformational plasticity in antigen presentation. Front Immunol. 2017; 8. doi:10.3389/fimmu.2017.00292

  9. Taylor EB, et al. Natural killer cells and T lymphocytes in pregnancy and pre-eclampsia. Clin Sci. 2017; 131 (24): 2911-17. doi:10.1042/CS20171070

  10. Caligiuri MA. Human natural killer cells. Blood. 2008; 112 (3): 461-69. doi:10.1182/blood-2007-09-077438

  11. Claudio-Piedras F, et al. Evolución y filogenia de los linfocitos B. Rev Alerg México. 2016; 63 (2): 190. doi:10.29262/ ram.v63i2.150

  12. Franasiak JM, Scott RT. Contribution of immunology to implantation failure of euploid embryos. Fertil Steril. 2017; 107 (6): 1279-83. doi:10.1016/j.fertnstert.2017.04.019

  13. Kalu E, et al. Serial estimation of Th1:th2 cytokines profile in women undergoing in-vitro fertilization-embryo transfer. Am J Reprod Immunol 2008; 59 (3): 206-11. doi:10.1111/ j.1600-0897.2007.00565.x

  14. Raghupathy R. Th 1-type immunity is incompatible with successful pregnancy. Immunol Today. 1997; 18 (10): 478- 82. doi:10.1016/S0167-5699(97)01127-4.

  15. Del Prete G, et al. Human Th1 and Th2 cells: functional properties, mechanisms of regulation, and role in disease. Lab Investig J Tech Methods Pathol. 1994; 70 (3): 299-306. PMID: 8145524

  16. Moffett A, et al. Maternal allo-recognition of the fetus. Fertil Steril. 2017; 107 (6): 1269-72. doi:10.1016/j.fertnstert. 2017.05.001

  17. Moser G, et al. Human trophoblast invasion: new and unexpected routes and functions. Histochem Cell Biol. 2018; 150 (4): 361-70. doi:10.1007/s00418-018-1699-0

  18. Moffett A, Colucci F. Uterine NK cells: active regulators at the maternal-fetal interface. J Clin Invest. 2014; 124 (5): 1872-79. doi:10.1172/JCI68107

  19. King A, et al. Recognition of trophoblast HLA Class I molecules by decidual NK Cell Receptors—A Review. Placenta. 2000; 21: S81-S85. doi:10.1053/plac.1999.0520

  20. Apps R, et al. Human leucocyte antigen (HLA) expression of primary trophoblast cells and placental cell lines, determined using single antigen beads to characterize allotype specificities of anti-HLA antibodies: HLA expression in the placenta. Immunology. 2009; 127 (1): 26-39. doi:10.1111/j.1365-2567.2008.03019.x

  21. Parham P, Moffett A. Variable NK cell receptors and their MHC class I ligands in immunity, reproduction and human evolution. Nat Rev Immunol. 2013; 13 (2): 133-44. doi:10.1038/nri3370

  22. Bélanger S, et al. Impaired natural killer cell self-education and “missing-self” responses in Ly49-deficient mice. Blood. 2012; 120 (3): 592-602. doi:10.1182/ blood-2012-02-408732

  23. Kärre K, et al. Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defense strategy. J Immunol Baltim 2005; 174 (11): 6566-69. PMID: 15905492

  24. Vivier E, et al. Innate or adaptive immunity? The example of natural killer cells. Science. 2011; 331 (6013): 44-49. doi:10.1126/science.1198687

  25. Koopman LA, et al. Human decidual natural killer cells are a unique NK cell subset with immunomodulatory potential. J Exp Med. 2003; 198 (8): 1201-12. doi:10.1084/ jem.20030305

  26. Horowitz A, et al. Genetic and environmental determinants of human NK cell diversity revealed by mass cytometry. Sci Transl Med. 2013; 5 (208): 208ra145-208ra145. doi:10.1126/scitranslmed.3006702

  27. Cristiani CM, et al. Human NK cell subsets in pregnancy and disease: Toward a new biological complexity. Front Immunol. 2016; 7. doi:10.3389/fimmu.2016.00656

  28. Moffett A, Shreeve N. First do no harm: uterine natural killer (NK) cells in assisted reproduction. Hum Reprod Oxf Engl. 2015; 30 (7): 1519-25. doi:10.1093/humrep/dev098

  29. Dosiou C, Giudice LC. Natural killer cells in pregnancy and recurrent pregnancy loss: endocrine and immunologic perspectives. Endocr Rev. 2005; 26 (1): 44-62. doi:10.1210/ er.2003-0021

  30. Trundley A, Moffett A. Human uterine leukocytes and pregnancy. Tissue Antigens. 2004; 63 (1): 1-12. doi:10.1111/ j.1399-0039.2004.00170.x

  31. Raulet DH, et al. Regulation of the natural killer cell receptor repertoire. Annu Rev Immunol. 2001; 19: 291-330. doi:10.1146/annurev.immunol.19.1.291

  32. Vilches C, Parham P. KIR: diverse, rapidly evolving receptors of innate and adaptive immunity. Annu Rev Immunol. 2002; 20: 217-51. doi:10.1146/annurev.immunol. 20.092501.134942

  33. Moffett A, Colucci F. Co-evolution of NK receptors and HLA ligands in humans is driven by reproduction. Immunol Rev. 2015; 267 (1): 283-97. doi:10.1111/imr.12323

  34. Alecsandru D, García-Velasco JA. Why natural killer cells are not enough: a further understanding of killer immunoglobulin-like receptor and human leukocyte antigen. Fertil Steril. 2017; 107 (6): 1273-78. doi:10.1016/j. fertnstert.2017.04.018

  35. Uhrberg M, et al. Human diversity in killer cell inhibitory receptor genes. Immunity. 1997; 7 (6): 753-63. doi:10.1016/ s1074-7613(00)80394-5

  36. Winter CC, et al. Direct binding and functional transfer of NK cell inhibitory receptors reveal novel patterns of HLA-C allotype recognition. J Immunol Baltim Md. 1998; 161 (2): 571-77. PMID 9670929

  37. Hiby SE, et al. Maternal activating KIRs protect against human reproductive failure mediated by fetal HLA-C2. J Clin Invest. 2010; 120 (11): 4102-10. doi:10.1172/ JCI43998

  38. Wang S, et al. Recurrent miscarriage is associated with a decline of decidual natural killer cells expressing killer cell immunoglobulin-like receptors specific for human leukocyte antigen C. J Obstet Gynaecol Res. 2014; 40 (5): 1288-95. doi:10.1111/jog.12329

  39. Hiby SE, et al. Association of maternal killer-cell immunoglobulin- like receptors and parental HLA-C genotypes with recurrent miscarriage. Hum Reprod Oxf Engl. 2008; 23 (4): 972-76. doi:10.1093/humrep/den011

  40. Savasi VM, et al. Maternal and fetal outcomes in oocyte donation pregnancies. Hum Reprod Update. 2016; 22 (5): 620-33. doi:10.1093/humupd/dmw012

  41. Alecsandru D, et al. Maternal KIR haplotype influences live birth rate after double embryo transfer in IVF cycles in patients with recurrent miscarriages and implantation failure. Hum Reprod Oxf Engl. 2014; 29 (12): 2637-43. doi:10.1093/humrep/deu251




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Ginecol Obstet Mex. 2020;88